Overview of nontuberculous mycobacterial disease in children. (6th January 2021)

• Record Type: Journal Article
• Authors: Ford, Timothy J; Silcock, Robyn A; Holland, Steven M
• Is Part Of: Journal of paediatrics and child health. Volume 57:Number 1(2021)
• Page Start: 15
• Page End: 18
• Publication Date: 2021-01-06
• Subjects: immunodeficiency -- interferon gamma receptor -- lymphadenitis -- nontuberculous mycobacteria -- pediatrics; Children -- Health and hygiene -- Periodicals; Pediatrics -- Periodicals; 618.92
• DOI: 10.1111/jpc.15257
• Languages: English
• ISSNs: 1034-4810

Abstract

Abstract : Nontuberculous mycobacteria (NTM) are ubiquitous organisms in our surrounding environment. Four distinct clinical syndromes associated with NTM infection have been described: skin and soft tissue disease, lymphadenitis, disseminated disease and pulmonary disease. In children, lymphadenitis is the most common NTM clinical entity, particularly affecting those aged 1–5 years who have no known risk factors for disease. Optimal management of NTM lymphadenitis is not entirely clear, although surgical intervention is likely a definitive therapy. Disseminated NTM disease is uncommon and only seen in the setting of immunocompromise. In previously well children, this presentation should always lead to consideration of an underlying immune defect, such as Mendelian susceptibility to mycobacterial disease. Identification of the underlying cause enables more targeted therapy and better prognostic understanding. Pulmonary NTM disease is fundamentally different to the other clinical syndromes, presenting in different hosts, who have different comorbidities, and follow a different clinical course.